荣昌生物（09995）今日盘中大跌5.20%，截至上午9时49分，该股报54.75港元。这一显著跌幅引起了市场的广泛关注。
分析认为，此次下跌可能与南向资金减持及投资者获利回吐有关。数据显示，6月12日南向资金减持荣昌生物150.20万股，同时该股近5个交易日累计上涨21.88%，近20个交易日更是上涨39.93%。如此高涨幅之后，部分投资者选择获利了结，导致股价回调。此外，当日早盘资金流向数据显示，该股资金流出1.11974亿港元，远高于流入的8339万港元，这也加剧了股价下跌压力。
值得注意的是，尽管短期内出现回调，但荣昌生物的长期发展前景仍受市场看好。最新财报显示，公司一季度主营收入同比上升59.17%，达5.26亿元。同时，在所有24家参与评级的机构中，75%的券商给予买入建议，25%给予持有建议，显示出机构对公司未来发展的信心。然而，投资者仍需警惕，生物科技行业的高风险特性可能导致股价的剧烈波动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.